| Serum/glucocorticoid-regulated kinase 1 contributes to the proliferation of varicella-zoster virus and induction of cyclin B1 expression. | Serum/glucocorticoid-regulated kinase 1 contributes to the proliferation of varicella-zoster virus and induction of cyclin B1 expression.
Oda S, Yokoyama A, Kishii R, Nagasawa M. | 06/25/2024 |
| Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability. | Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
Tuluhong D, Gao H, Li X, Wang L, Zhu Y, Xu C, Wang J, Li H, Li Q, Wang S. | 06/10/2024 |
| Hsa-circ-0006091 modulates the proliferation of hepatocellular carcinoma via the miR-622/CCNB1 axis. | Hsa-circ-0006091 modulates the proliferation of hepatocellular carcinoma via the miR-622/CCNB1 axis.
Zhao X, He L., Free PMC Article | 06/6/2024 |
| BubR1 and cyclin B1 immunoexpression in pleomorphic adenoma and polymorphous adenocarcinoma of minor salivary glands. | BubR1 and cyclin B1 immunoexpression in pleomorphic adenoma and polymorphous adenocarcinoma of minor salivary glands.
Cavalcante IL, Silva Barros CCD, Colares DF, Cruz VMS, de Andrade BAB, Nonaka CFW, Rabenhorst SHB, Cavalcante RB. | 02/2/2024 |
| Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis. | Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
Kang J, Jung H, Kim H., Free PMC Article | 02/1/2024 |
| KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1. | KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1.
Xiao B, Xiang Q, Deng Z, Chen D, Wu S, Zhang Y, Liang Y, Wei S, Luo G, Li L., Free PMC Article | 02/1/2024 |
| DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway. | DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway.
Fei H, Shi X, Li S, Li Y, Yin X, Wu Z, Wang W, Shi H, Li R. | 01/26/2024 |
| A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors. | A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.
Dai P, Xiong L, Wei Y, Wei X, Zhou X, Zhao J, Tang H., Free PMC Article | 12/20/2023 |
| The role of CXCL8 and CCNB1 in predicting hepatocellular carcinoma in the context of cirrhosis: implications for early detection and immune-based therapies. | The role of CXCL8 and CCNB1 in predicting hepatocellular carcinoma in the context of cirrhosis: implications for early detection and immune-based therapies.
Sun Q, An R, Li J, Liu C, Wang M, Wang C, Wang Y. | 08/31/2023 |
| Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma. | Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma.
Li H, Yang C, Chen K, Sun M., Free PMC Article | 06/2/2023 |
| The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development. | The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI, Toss MS, Green AR, Rakha EA., Free PMC Article | 03/27/2023 |
| FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. | FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.
Almeida LY, Moreira FDS, Santos GASD, Cuadra Zelaya FJM, Ortiz CA, Agostini M, Mariano FS, Bastos DC, Daher URN, Kowalski LP, Coletta RD, Graner E. | 02/11/2023 |
| CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine. | CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine.
Chen X, Ma J, Wang X, Zi T, Qian D, Li C, Xu C., Free PMC Article | 01/14/2023 |
| miR-144 negatively regulates the effect of CCNB1 protein on the biological behavior of hepatoma cells. | miR-144 negatively regulates the effect of CCNB1 protein on the biological behavior of hepatoma cells.
Lan C, Xu Z, He S, Xian L, Song Z, Bin X, Li G. | 12/17/2022 |
| Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA. | Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA.
Zhao M, Wang Y, Tan F, Liu L, Hou X, Fan C, Tang L, Mo Y, Wang Y, Yan Q, Gong Z, Li Z, Liao Q, Guo C, Huang H, Zeng X, Li G, Zeng Z, Xiong W, Wang F. | 11/26/2022 |
| Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis. | Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis.
Zeng Y, Fan R., Free PMC Article | 10/8/2022 |
| High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer. | High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
Fu H, Li K, Wang S, Li Y., Free PMC Article | 09/24/2022 |
| MiR-139-5p Targeting CCNB1 Modulates Proliferation, Migration, Invasion and Cell Cycle in Lung Adenocarcinoma. | MiR-139-5p Targeting CCNB1 Modulates Proliferation, Migration, Invasion and Cell Cycle in Lung Adenocarcinoma.
Bao B, Yu X, Zheng W. | 07/16/2022 |
| CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. | CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.
Rong MH, Li JD, Zhong LY, Huang YZ, Chen J, Xie LY, Qin RX, He XL, Zhu ZH, Huang SN, Zhou XG., Free PMC Article | 05/7/2022 |
| Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers. | Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.
Fang L, Liu Q, Cui H, Zheng Y, Wu C., Free PMC Article | 04/30/2022 |
| Long noncoding RNA PTTG3P/miR-192-3p/CCNB1 axis is a potential biomarker of childhood asthma. | Long noncoding RNA PTTG3P/miR-192-3p/CCNB1 axis is a potential biomarker of childhood asthma.
Dai B, Sun F, Cai X, Li C, Liu F, Shang Y. | 03/26/2022 |
| CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway. | CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM, Cao Y, Zhao PS, Wu LY, Lu YM, Wang YL, Zhao JF, Liu XG., Free PMC Article | 03/26/2022 |
| An Oxidative Stress-Related Gene Pair (CCNB1/PKD1), Competitive Endogenous RNAs, and Immune-Infiltration Patterns Potentially Regulate Intervertebral Disc Degeneration Development. | An Oxidative Stress-Related Gene Pair (CCNB1/PKD1), Competitive Endogenous RNAs, and Immune-Infiltration Patterns Potentially Regulate Intervertebral Disc Degeneration Development.
Cao S, Liu H, Fan J, Yang K, Yang B, Wang J, Li J, Meng L, Li H., Free PMC Article | 02/12/2022 |
| MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1. | MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
Xiao X, Rui B, Rui H, Ju M, Hongtao L. | 02/5/2022 |
| Proteasome inhibitors decrease paclitaxelinduced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1. | Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1.
Hu L, Pan X, Hu J, Zeng H, Liu X, Jiang M, Jiang B., Free PMC Article | 01/22/2022 |